994 related articles for article (PubMed ID: 30927924)
1. Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression.
Huang X; Li Z; Zhang Q; Wang W; Li B; Wang L; Xu Z; Zeng A; Zhang X; Zhang X; He Z; Li Q; Sun G; Wang S; Li Q; Wang L; Zhang L; Xu H; Xu Z
Mol Cancer; 2019 Mar; 18(1):71. PubMed ID: 30927924
[TBL] [Abstract][Full Text] [Related]
2. Circular RNA MCTP2 inhibits cisplatin resistance in gastric cancer by miR-99a-5p-mediated induction of MTMR3 expression.
Sun G; Li Z; He Z; Wang W; Wang S; Zhang X; Cao J; Xu P; Wang H; Huang X; Xia Y; Lv J; Xuan Z; Jiang T; Fang L; Yang J; Zhang D; Xu H; Xu Z
J Exp Clin Cancer Res; 2020 Nov; 39(1):246. PubMed ID: 33198772
[TBL] [Abstract][Full Text] [Related]
3. CircRNACCDC66 regulates cisplatin resistance in gastric cancer via the miR-618/BCL2 axis.
Zhang Q; Miao Y; Fu Q; Hu H; Chen H; Zeng A; Jin Y; Jiang Y; Qian L; Wu L; Xu L; Wang G; Qiu L; Huang X; Xia Y
Biochem Biophys Res Commun; 2020 Jun; 526(3):713-720. PubMed ID: 32253030
[TBL] [Abstract][Full Text] [Related]
4. Circ_0017274 acts on miR-637/CDX2 axis to facilitate cisplatin resistance in gastric cancer.
Xu B; Guo J; Chen M
Clin Exp Pharmacol Physiol; 2022 Oct; 49(10):1105-1115. PubMed ID: 35748299
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA circ_0001017 Sensitizes Cisplatin-Resistant Gastric Cancer Cells to Chemotherapy by the miR-543/PHLPP2 Axis.
Zhang J; Zha W; Qian C; Ding A; Mao Z
Biochem Genet; 2022 Apr; 60(2):558-575. PubMed ID: 34313883
[TBL] [Abstract][Full Text] [Related]
6. circCUL2 regulates gastric cancer malignant transformation and cisplatin resistance by modulating autophagy activation via miR-142-3p/ROCK2.
Peng L; Sang H; Wei S; Li Y; Jin D; Zhu X; Li X; Dang Y; Zhang G
Mol Cancer; 2020 Nov; 19(1):156. PubMed ID: 33153478
[TBL] [Abstract][Full Text] [Related]
7. CircAKT3 inhibits glycolysis balance in lung cancer cells by regulating miR-516b-5p/STAT3 to inhibit cisplatin sensitivity.
Xu Y; Jiang T; Wu C; Zhang Y
Biotechnol Lett; 2020 Jul; 42(7):1123-1135. PubMed ID: 32170433
[TBL] [Abstract][Full Text] [Related]
8. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
Zhou J; Chen Q
FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin.
Jia Y; Tian C; Wang H; Yu F; Lv W; Duan Y; Cheng Z; Wang X; Wang Y; Liu T; Wang J; Liu L
Mol Cancer; 2021 Dec; 20(1):162. PubMed ID: 34893064
[TBL] [Abstract][Full Text] [Related]
10. N6-methyladenosine-modified circPLPP4 sustains cisplatin resistance in ovarian cancer cells via PIK3R1 upregulation.
Li H; Lin R; Zhang Y; Zhu Y; Huang S; Lan J; Lu N; Xie C; He S; Zhang W
Mol Cancer; 2024 Jan; 23(1):5. PubMed ID: 38184597
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA circ-PVT1 contributes to paclitaxel resistance of gastric cancer cells through the regulation of ZEB1 expression by sponging miR-124-3p.
Liu YY; Zhang LY; Du WZ
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31793989
[TBL] [Abstract][Full Text] [Related]
12. CircAKT3 promotes cell proliferation, survival and glutamine metabolism of gastric cancer by activating SLC1A5 expression via targeting miR-515-5p.
Li F; Zhang L; Sun Q
Histol Histopathol; 2022 Mar; 37(3):227-241. PubMed ID: 34850965
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of circular RNA circ-DCAF6 predicts adverse prognosis and promotes cell progression via sponging miR-1231 and miR-1256 in gastric cancer.
Wu L; Liu D; Yang Y
Exp Mol Pathol; 2019 Oct; 110():104273. PubMed ID: 31226266
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA circ_0026359 Enhances Cisplatin Resistance in Gastric Cancer via Targeting miR-1200/POLD4 Pathway.
Zhang Z; Yu X; Zhou B; Zhang J; Chang J
Biomed Res Int; 2020; 2020():5103272. PubMed ID: 32855967
[TBL] [Abstract][Full Text] [Related]
15. circUBAP2 inhibits cisplatin resistance in gastric cancer via miR-300/KAT6B axis.
Cheng W; Luan P; Jin X
Anticancer Drugs; 2023 Jan; 34(1):126-134. PubMed ID: 36206113
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA circCCDC9 acts as a miR-6792-3p sponge to suppress the progression of gastric cancer through regulating CAV1 expression.
Luo Z; Rong Z; Zhang J; Zhu Z; Yu Z; Li T; Fu Z; Qiu Z; Huang C
Mol Cancer; 2020 May; 19(1):86. PubMed ID: 32386516
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA CircCACTIN Promotes Gastric Cancer Progression by Sponging MiR-331-3p and Regulating TGFBR1 Expression.
Zhang L; Song X; Chen X; Wang Q; Zheng X; Wu C; Jiang J
Int J Biol Sci; 2019; 15(5):1091-1103. PubMed ID: 31182928
[No Abstract] [Full Text] [Related]
18. A novel circular RNA circFN1 enhances cisplatin resistance in gastric cancer via sponging miR-182-5p.
Huang XX; Zhang Q; Hu H; Jin Y; Zeng AL; Xia YB; Xu L
J Cell Biochem; 2020 Jan; ():. PubMed ID: 31898357
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
Zheng H; Wang JJ; Yang XR; Yu YL
World J Gastroenterol; 2020 Feb; 26(5):499-513. PubMed ID: 32089626
[TBL] [Abstract][Full Text] [Related]
20. Circ-ILF2 in oral squamous cell carcinoma promotes cisplatin resistance and induces M2 polarization of macrophages.
Wu S; Lv X; Wei H; Chen W; Zheng J; Li X; Song J; Ai Y; Zou C
J Cell Mol Med; 2023 Dec; 27(24):4133-4144. PubMed ID: 37864310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
